On the contrary, this NRF2 signature did not have the same immunoevasive phenotype in other non-squamous cancer types including renal papillary carcinoma, hepatocellular carcinoma or bladder carcinoma [63]. This evidence concerns the gene NFE2L2 and urinary bladder carcinoma.